CNS Diseases World Summit 2014
18 Sep 2014 - 19 Sep 2014 - San Francisco, CA, USA
With the growing unmet need for disease-modifying treatments in CNS disorders such as Alzheimer's, Parkinson's, autism, and ALS, it is time for us to think of better ways to partner and conduct research.
What are opportunities for working with patient advocacy groups?
How do small companies and start-ups fit in the space, especially give pharma's decreased involvement?
What is the role of private/public partnerships?
What are the research opportunities and risks associated with rare CNS disorders?
The CNS Disease World Summit is a comprehensive meeting that seeks to answer such questions.